09:08 EDT Viatris agrees to divest Women’s Healthcare unit, API unit in India
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on VTRS:
- Early notable gainers among liquid option names on October 2nd
- Viatris (NASDAQ:VTRS) Rises on Key Business Divestments
- Viatris Announces Agreements on Remaining Planned Divestitures; Upon Closing Would Achieve its Original Total Target of a Multiple Above 12x on 2022 Estimated Adjusted EBITDA
- Viatris call volume above normal and directionally bullish
- Viatris and Ocuphire announce FDA approved RYZUMVI to treat mydriasis